Main navigation

• Home
• Our medicines
• Diseases and conditions
• Community support
• Help affording your medicines
• Research & development
• Healthcare professionals
• Careers
• About AstraZeneca US
  • Investors
  • Our company
  • AZ on the issues
  • Responsible business
  • Newsroom
    • Media resources
    • All news
    • Corporate news
    • Financial news
    • Product news
    • Research news
  • US web sites
  • Contact us

You are here

• Home
• About AstraZeneca US
• Newsroom

• News

The following shows headlines of all news articles published within 12-months, starting from most recent.

• Pages
• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• Next

• • Jun 16, 2009
  • Philadelphia cancer patients to benefit from expansion of the American Cancer Society Patient Navigator Program  
• • Jun 10, 2009
  • Favorable vote from FDA Advisory Committee on SEROQUEL pediatric Supplemental New Drug Applications  
• • Jun 4, 2009
  • AstraZeneca and Abbott extend relationship to include co-promotion of TRILIPIX® (fenofibric acid)  
• • Jun 4, 2009
  • AstraZeneca and Abbott submit New Drug Application to the FDA for CERTRIAD™, an investigational treatment for mixed dyslipidemia  
• • Jun 2, 2009
  • AstraZeneca studies show relief of nighttime heartburn and reduction in GERD-related sleep disturbances  
• • May 30, 2009
  • Phase III study data with vandetanib (ZACTIMA™) in patients with advanced non-small cell lung cancer (NSCLC) presented at American Society of Clinical Oncology  
• • May 21, 2009
  • AstraZeneca to disclose compensation to U.S. doctors  
• • May 20, 2009
  • Court grants AstraZeneca preliminary injunction against Apotex in PULMICORT RESPULES patent litigation  
• • May 20, 2009
  • AstraZeneca, the National Alliance for Hispanic Health and LULAC join forces to promote needed heart health education in Hispanic communities  
• • May 20, 2009
  • AstraZeneca and Banner Alzheimer’s Institute expand Alzheimer’s disease collaboration  

• Pages
• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• Next

Page tools

• Print
• Bookmark this page
• Subscribe to RSS news feed